Benton Susan 4
4 · Ocuphire Pharma, Inc. · Filed Nov 13, 2020
Insider Transaction Report
Form 4
Benton Susan
Director
Transactions
- Award
Stock Option (right to buy)
2020-11-11+50,000→ 50,000 totalExercise: $4.05Exp: 2030-11-11→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]16,666 shares vest each twelve month period ending October 31, 2021 and October 31, 2022 and the balance vest October 31, 2023.